Search clinical trials for: Symptomatic Over Active Bladder

Total 10000 results

Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

Overactive Bladder

Poland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
DJO UK Ltd
Donawa Lifescience Consulting S.r.l.

Recruiting

Cefar URO - Symptomatic Treatment of Overactive Bladder

Overactive Bladder (OAB) | Refractory Overactive Bladder | Urinary Urgency and Frequency

France
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Astellas Pharma Inc

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

Urinary Bladder, Overactive

Japan
Queen Mary University of London
Barts & The London NHS Trust; University of Hertfordshire

Completed

Examination of Whether an Exercise Programme Reduces Alcohol Consumption Among Alcohol-Dependent Adults (AOA)

Alcohol Use Disorder | Alcohol Abuse or Dependence

United Kingdom

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe